Hybrid Conferencee

International Workshop on Immunology and Vaccine Development (IWIVD - 26)

29th - 30th September 2026 | Nice, France

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Nice. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Nice event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Nice conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Nice, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Nice."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Vaccine Design

This track will explore innovative approaches to vaccine design, focusing on the integration of novel adjuvants and antigen discovery techniques. Participants will discuss the implications of these advancements for enhancing vaccine efficacy and immunogenicity.

Track 02

Clinical Trials in Vaccine Development

This session will delve into the methodologies and challenges associated with conducting clinical trials for new vaccines. Emphasis will be placed on evaluating vaccine safety, efficacy, and the regulatory landscape.

Track 03

Immunogenicity and Immune Response

This track will examine the mechanisms underlying immunogenicity and the immune response elicited by various vaccine platforms. Discussions will include factors influencing immune memory and long-term protection.

Track 04

Infectious Disease Prevention Strategies

This session will focus on the role of vaccines in preventing infectious diseases, highlighting successful case studies and emerging threats. Participants will analyze the impact of vaccination programs on public health outcomes.

Track 05

Novel Vaccines: Trends and Innovations

This track will showcase cutting-edge research on novel vaccine technologies, including mRNA and viral vector platforms. Participants will discuss the potential of these innovations to address unmet medical needs.

Track 06

Vaccine Delivery Systems

This session will explore the latest advancements in vaccine delivery systems, including needle-free methods and microneedle technology. Emphasis will be placed on improving vaccine accessibility and patient compliance.

Track 07

Immunotherapy and Vaccine Synergy

This track will investigate the intersection of immunotherapy and vaccine development, focusing on how these approaches can be combined to enhance therapeutic outcomes. Discussions will include case studies and future directions.

Track 08

Molecular Vaccines: Design and Application

This session will cover the design and application of molecular vaccines, including DNA and protein-based platforms. Participants will discuss the challenges and opportunities presented by these innovative technologies.

Track 09

Viral and Bacterial Vaccine Development

This track will focus on the unique challenges associated with developing vaccines for viral and bacterial pathogens. Discussions will include strategies for overcoming these challenges and enhancing vaccine effectiveness.

Track 10

Immunological Assays in Vaccine Research

This session will highlight the importance of immunological assays in evaluating vaccine performance and safety. Participants will discuss the latest methodologies and their implications for vaccine research.

Track 11

Vaccine Safety and Public Perception

This track will address the critical issue of vaccine safety and its impact on public perception and vaccination rates. Participants will explore strategies for improving communication and trust in vaccine science.